Suntrust Banks’s Regeneron Pharmaceuticals REGN Stock Holding History

Suntrust Banks’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-919	Closed	-$377K	–	1346
2019 Q1	$377K	Sell	919 -237	-21%	-$97.6K	﹤0.01%	1023
2018 Q4	$432K	Sell	1,156 -184	-14%	-$67.3K	﹤0.01%	936
2018 Q3	$541K	Sell	1,340 -180	-12%	-$68.5K	﹤0.01%	891
2018 Q2	$524K	Sell	1,520 -63	-4%	-$19.7K	﹤0.01%	902
2018 Q1	$545K	Sell	1,583 -625	-28%	-$217K	﹤0.01%	870
2017 Q4	$830K	Sell	2,208 -2,119	-49%	-$858K	﹤0.01%	742
2017 Q3	$1.93M	Buy	4,327 +2,455	+131%	+$1.17M	0.01%	543
2017 Q2	$919K	Sell	1,872 -11	-0.6%	-$4.81K	0.01%	676
2017 Q1	$730K	Sell	1,883 -1,263	-40%	-$468K	﹤0.01%	739
2016 Q4	$1.15M	Buy	3,146 +555	+21%	+$211K	0.01%	737
2016 Q3	$1.04M	Buy	2,591 +642	+33%	+$258K	0.01%	738
2016 Q2	$680K	Sell	1,949 -2,054	-51%	-$791K	﹤0.01%	837
2016 Q1	$1.44M	Buy	4,003 +171	+4%	+$70.5K	0.01%	579
2015 Q4	$2.08M	Buy	3,832 +3,383	+753%	+$1.83M	0.01%	450
2015 Q3	$208K	Sell	449 -399	-47%	-$214K	﹤0.01%	1140
2015 Q2	$431K	Buy	848 +145	+21%	+$70.8K	﹤0.01%	896
2015 Q1	$316K	Sell	703 -33	-4%	-$14K	﹤0.01%	1006
2014 Q4	$301K	Sell	736 -7,433	-91%	-$2.92M	﹤0.01%	974
2014 Q3	$2.94M	Sell	8,169 -845	-9%	-$283K	0.02%	347
2014 Q2	$2.55M	Buy	9,014 +1,482	+20%	+$439K	0.02%	391
2014 Q1	$2.26M	Sell	7,532 -138	-2%	-$42.5K	0.01%	634
2013 Q4	$2.11M	Sell	7,670 -569	-7%	-$164K	0.01%	647
2013 Q3	$2.58M	Sell	8,239 -747	-8%	-$196K	0.01%	593
2013 Q2	$2.02M	Buy	+8,986	New	+$2.09M	0.01%	614

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Suntrust Banks's REGN Position: Q2 2019 in Review

Suntrust Banks sold out of Regeneron Pharmaceuticals (REGN) in Q2 2019, closing a stake of 919 shares — an estimated $377K sold.

Suntrust Banks first reported a position in REGN in Q2 2013 and held it in 24 quarters. The position peaked at $2.94M in Q3 2014. 658 funds tracked by Wall St. Rank hold REGN as of Q2 2019.

Suntrust Banks reported no remaining Regeneron Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Suntrust Banks sold 919 Regeneron Pharmaceuticals shares in Q2 2019, an estimated $377K.
Suntrust Banks first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 24 quarters.
Suntrust Banks's Regeneron Pharmaceuticals position peaked at $2.94M in Q3 2014.
658 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2019.

Based on Suntrust Banks's 13F filing for Q2 2019, filed 6 Aug 2019.